Cat.#: ASSD-123
Description | Competitive fluorescent β2-adrenoceptor antagonist. Displays selectivity for β2 over β1 and β3 (apparent KD values are 9.21, 7.76 and 7.09 respectively). Antagonizes the activity of isoprenaline, a non-selective β-adrenoceptor agonist. Exhibits no intrinsic agonist activity. |
Synonyms | β2-633-AN2 |
Size | 500 μg |
Applications | For imaging at β1 / β2 / β3 adrenoceptors use solutions up to 100 nM. |
Molecule Weight | 894 |
Purity | >95% |
Solubility | Soluble in DMSO |
Excitation | 633 nm |
Emission | 650 nm |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-191 | Fluorescein 6-Isothiocyanate, Isomer 2, 95% (AC191) | 100 mg | inquiry |
ASSD-186 | Bromocresol Purple (AC186) | 5 g, 10 g | inquiry |
ASSD-114 | Acridine Orange hydrochloride (AC114) | 50 mg | inquiry |
ASSD-127 | Fluorescent H3 antagonist [clobenpropit] (AC127) | 50 μg | inquiry |
ASSD-194 | 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) | 100 mg | inquiry |
ASSD-187 | Quinaldine Red (AC187) | 5 g, 25 g, 100 g, 250 g | inquiry |
ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
ASSD-201 | Fluoresceinamine Hydrochloride Isomer 1 (AC201) | 2 g | inquiry |
ASSD-115 | 7-Amino-4-methylcoumarin (AC115) | 100 mg, 500 mg, 1 g | inquiry |
ASSD-211 | 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) | 100 mg, 1 g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.